- Home
- BROG vs TIL Comparison
BROG vs TIL Comparison
Compare BROG & TIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BROG
- TIL
- Stock Information
- Founded
- BROG 2019
- TIL 2018
- Country
- BROG United Arab Emirates
- TIL United States
- Employees
- BROG N/A
- TIL N/A
- Industry
- BROG Integrated oil Companies
- TIL Biotechnology: Pharmaceutical Preparations
- Sector
- BROG Energy
- TIL Health Care
- Exchange
- BROG Nasdaq
- TIL Nasdaq
- Market Cap
- BROG 143.6M
- TIL 134.5M
- IPO Year
- BROG N/A
- TIL 2021
- Fundamental
- Price
- BROG $1.38
- TIL $20.80
- Analyst Decision
- BROG
- TIL Buy
- Analyst Count
- BROG 0
- TIL 4
- Target Price
- BROG N/A
- TIL $100.33
- AVG Volume (30 Days)
- BROG 17.4K
- TIL 110.1K
- Earning Date
- BROG 02-15-2025
- TIL 11-13-2024
- Dividend Yield
- BROG N/A
- TIL N/A
- EPS Growth
- BROG N/A
- TIL N/A
- EPS
- BROG N/A
- TIL N/A
- Revenue
- BROG $105,695,648.00
- TIL N/A
- Revenue This Year
- BROG N/A
- TIL N/A
- Revenue Next Year
- BROG N/A
- TIL $2.65
- P/E Ratio
- BROG N/A
- TIL N/A
- Revenue Growth
- BROG 29.62
- TIL N/A
- 52 Week Low
- BROG $0.80
- TIL $6.88
- 52 Week High
- BROG $6.66
- TIL $92.00
- Technical
- Relative Strength Index (RSI)
- BROG 46.84
- TIL 36.46
- Support Level
- BROG $1.26
- TIL $19.01
- Resistance Level
- BROG $1.98
- TIL $22.69
- Average True Range (ATR)
- BROG 0.16
- TIL 2.53
- MACD
- BROG 0.01
- TIL -0.27
- Stochastic Oscillator
- BROG 18.92
- TIL 10.72
About BROG Brooge Energy Limited
Brooge Energy Ltd is an Oil Refinery & Storage Company in the United Arab Emirates. The company generates revenue from the leasing of storage capacity of tanks and other ancillary services.
About TIL Instil Bio Inc.
Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize FRα, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.